PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25975640-4	2015	A series of WZ4002 analogs, derived from anilinopyrimidine and 3-substituted-2-cyanoacrylamide scaffolds, exhibit strong and selective inhibitory activity against clinically relevant EGFR(L858R) and EGFR(L858R/T790M).	N-phenylpyrimidin-2-amine	41-58	epidermal growth factor receptor	Homo sapiens	183-187	
34636023-7	2021	Substructures such as anilinopyrimidine, acrylamide, amino phenyl, methoxy phenyl, and thienopyrimidinyl amide appeared more in highly active inhibitors against double-mutant EGFR.	N-phenylpyrimidin-2-amine	22-39	epidermal growth factor receptor	Homo sapiens	175-179	
23668441-0	2013	Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer.	N-phenylpyrimidin-2-amine	45-62	epidermal growth factor receptor	Homo sapiens	87-119	
23668441-1	2013	A series of hybrids (12a-k) from (phenylsulfonyl)furoxan and anilinopyrimidine were synthesized and biologically evaluated as epidermal growth factor receptor (EGFR) inhibitors for intervention of non-small-cell lung cancer (NSCLC).	N-phenylpyrimidin-2-amine	61-78	epidermal growth factor receptor	Homo sapiens	126-158	
23668441-1	2013	A series of hybrids (12a-k) from (phenylsulfonyl)furoxan and anilinopyrimidine were synthesized and biologically evaluated as epidermal growth factor receptor (EGFR) inhibitors for intervention of non-small-cell lung cancer (NSCLC).	N-phenylpyrimidin-2-amine	61-78	epidermal growth factor receptor	Homo sapiens	160-164	
10639288-3	1999	Several elaborations of the fundamental anilinopyrimidine pharmacophore have been reported as potent and selective inhibitors of the epidermal growth factor receptor (EGFr) tyrosine kinase.	N-phenylpyrimidin-2-amine	40-57	epidermal growth factor receptor	Homo sapiens	167-171	
29250520-0	2017	Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors.	N-phenylpyrimidin-2-amine	53-70	epidermal growth factor receptor	Homo sapiens	86-90